(Q43719555)

English

Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze

scientific article published in September 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze (English)

1 reference

Europe PubMed Central

26 November 2017

tetrahydrocannabinol

0 references

0 references

author name string

F Nava

1

1 reference

Europe PubMed Central

26 November 2017

G Carta

2

1 reference

Europe PubMed Central

26 November 2017

G Colombo

3

1 reference

Europe PubMed Central

26 November 2017

G L Gessa

4

1 reference

Europe PubMed Central

26 November 2017

publication date

1 September 2001

1 reference

Europe PubMed Central

26 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Neuropharmacology

1 reference

Europe PubMed Central

26 November 2017

41

1 reference

Europe PubMed Central

26 November 2017

3

1 reference

Europe PubMed Central

26 November 2017

392-399

1 reference

Europe PubMed Central

26 November 2017

Pharmacology of memory: cholinergic-glutamatergic interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Acute and chronic effects of ?9-Tetrahydrocannabinol on complex behavior of squirrel monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Delta 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Role of cyclic AMP in the actions of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid‐mediated blockade of long‐term potentiation in the rat hippocampal slice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Effects of drugs of abuse on acquisition of behavioral chains in squirrel monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Cognitive correlates of long-term cannabis use in Costa Rican men.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Marijuana's interaction with brain reward systems: update 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Adverse effects of cannabis

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Comparative effects of alcohol and marijuana on mood, memory, and performance

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Delta 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects with HA966.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

D(2) dopamine receptors enable delta(9)-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

The pharmacologic effects of daily marijuana smoking in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Acetylcholine in mind: a neurotransmitter correlate of consciousness?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

The residual neuropsychological effects of cannabis: the current status of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Enhancement of memory in cannabinoid CB1 receptor knock-out mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Effects of the enantiomers of (+/-)-HA-966 on dopamine neurons: an electrophysiological study of a chiral molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Do cognitive impairments recover following cessation of cannabis use ?

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Residual effects of chronic cannabis treatment on behavior in mature rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2801%2900075-2

7 January 2021

Identifiers

10.1016/S0028-3908(01)00075-2

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43719555&oldid=2102816334"